Previous studies have demonstrated that ethnicity plays a role in the prevalence, isotype distribution, and clinical significance of anticardiolipin (aCL) and anti-β2 glycoprotein I (aβ2-GPI) antibodies in systemic lupus erythematosus (SLE) patients. Few studies have been done in Latin American populations. Serum samples from 129 Chilean SLE patients were tested for IgG, IgM and IgA aCL and aβ2-GPI by ELISA. Clinical data were reviewed with the focus on clinical manifestations of antiphospholipid syndrome (APS). Positivity for at least one isotype of aCL was found in 30% of patients, while only 10% were positive for at least one isotype of aβ2-GPI. IgG was the most prevalent isotype for aCL (16%), and the isotype distribution was similar (4%) for aβ2-GPI. In general, the presence of aCL was significantly associated with the presence of aβ2-GPI, but a number of samples were positive for only one antibody, some of them associated with clinical manifestations of APS. ACL antibodies at medium-high titers were significantly correlated with thrombosis (P/0.0007) and fetal loss (P/0.009); however, the sensitivity of aβ2-GPI for detecting thrombosis and fetal loss was lower than aCL (19 and 17% vs 56 and 50%, respectively), and the specificity slightly higher (91 and 90% vs 84 and 82%). In Chilean SLE patients, aCL and aβ2-GPI antibodies are important in the evaluation of patients with APS. However, the utility of aβ2-GPI antibodies was limited by the low prevalence of these antibodies in comparison with other ethnic groups. Further studies are needed to define the basis of the observed differences among ethnic groups.
Galli M , Comfurius P , Maassen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor . Lancet1990; 335: 1544-1547 .
2.
McNeil HP , Simpson RJ , Chesterman CN , Krilis SA . Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H) . Proc Natl Acad Sci USA1990; 87: 4120-4124 .
3.
Matsuura E , Igarashi Y , Fujimoto M , Ichikawa K , Koike T . Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease . Lancet1990; 336: 177-178 .
4.
Arvieux J , Roussel B , Jacob MC , Colomb MG . Measurement of antiphospholipid antibodies by ELISA using β2-glycoprotein I as an antigen . J Immunol Meth1991; 143: 223-229 .
5.
Viard JP , Amoura Z , Bach JF . Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus . Am J Med1992; 93: 181-186 .
6.
Keeling DM , Wilson AJG , Mackie IJ , Machin SJ , Isenberg DA . Some ‘antiphospholipid antibodies’ bind to β2-glycoprotein I in the absence of phospholipid . Br J Haematol1992; 82: 571-574 .
7.
Roubey RAS , Eisenberg RA , Harper MF , Winfield JB . ‘Anticardiolipin’ autoantibodies recognize β2-glycoprotein I in the absence of phospholipid . Importance of Ag density and bivalent binding. J Immunol1995; 154: 954-960 .
8.
Pierangeli SS , Wei Liu X , Barker JH , Anderson G , Harris EN . Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome . Thromb Haemost199575: 1361-1367 .
9.
Blank M , Cohen J , Toder V , Shoenfeld Y . Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies . Proc Natl Acad Sci USA1991; 88: 3069-3073 .
10.
George J , Blank M , Levy Y et al. Differential effects of anti-β2glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphosphlipid syndrome . Circulation1998; 97: 900-906 .
11.
Di Simone N , Meroni PL , Del Papa N et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered β2-glycoprotein I . Arthritis Rheum2000; 43: 140-150 .
12.
Aron AL , Cuellar ML , Brey RL et al. Early onset of autoimmunity in MRL/++ mice following immunization with β2 glycoprotein I . Clin Exp Immunol1995; 101: 78-81 .
13.
Harris EN , Gharavi AE , Boey ML et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus . Lancet1983; ii: 1211-1214 .
14.
Harris EN , Chan JKH , Asherson RA , Aber VR , Uharavi AE , Hughes GRV . Thrombosis recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test . Arch Intern Med1986; 146: 2153-2156 .
15.
Alarcon-Segovia D , Deleze M , Oria CV et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients . Medicine1989; 68: 353-365 .
16.
Love PE , Santoro SA . Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders . Ann Intern Med1990; 112: 682-698 .
17.
Escalante A , Brey RL , Mitchell BD , Dreiner U . Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus . Am J Med1995; 98: 559-565 .
18.
Abu-Shakra M , Gladman DD , Urowitz MB . Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations . Am J Med1995; 99: 624-628 .
19.
Fanopoulos D , Teodorescu MR , Varga J , Teodorescu M . High frequency of abnormal levels of IgA Anti-β2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome . J Rheumatol1998; 25: 675-680 .
20.
Puurunen M , Vaarala O , Julkunen H , Aho K , Palosuo T . Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus . Clin Immunol Immunopathol1996; 80: 16-22 .
21.
Teixido M , Font J , Reverter JC et al. Anti-β2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome . Br J Rheumatol1997; 36: 113-116 .
22.
Guerin J , Feighery C , Sim RB , Jackson J . Antibodies to β2-glycoprotein I-a specific marker for the antiphospholipid syndrome . Clin Exp Immunol1997; 109: 304-309 .
23.
Day HM , Thiagarajan P , Ahn C , Reveille JD , Tinker KF , Arnett FC . Autoantibodies to β2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody test . J Rheumatol1998; 25: 667-674 .
24.
Sebastiani GD , Galeazzi M , Tincani A et al. Anticardiolipin and antiβ2 GPI antibodies in a large series of European patients with systemic lupus erythematosus . Scand J Rheumatol1999; 28: 344-351 .
25.
Gomez-Pacheco L , Villa AR , Drenkard C , Cabiedes J , Cabral AR , Alarcon-Segovia D . Serum anti-β2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients . Am J Med1999; 21: 417-423 .
26.
Cabiedes J , Cabral AR , Alarcon-Segovia D . Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-β2-glycoprotein-I than with antiphospholipid antibodies . J Rheumatol1995; 22: 1899-1906 .
27.
Amengual O , Atsumi T , Khamashta MA , Koike T , Hughes GRV . Specificity of ELISA for antibody to β2-Glycoprotein I in patients with antiphospholipid syndrome . Br J Rheumatol1996; 35: 1239-1243 .
28.
Tsutsumi A , Matsuura E , Ichikawa K et al. Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus . Arthritis Rheum1996; 39: 1466-1474 .
29.
Sanmarco M , Soler C , Christides C et al. Prevalence and clinical significance of IgG isotype anti-β2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies . J Lab Clin Med1997; 129: 499-506 .
30.
Detkova D , Gil-Aguado A , Lavilla P , Cuesta MV , Fontan G , PascualSalcedo D . Do antibodies to β2-glycoprotein I contribute to the better characterization of the antiphospholipid syndrome . Lupus1999; 8: 430-438 .
31.
EI-Kadi HS , Keil LB , DeBari VA . Analytical and clinical relationships between human IgG autoantibodies to β2 glycoprotein I and anticardiolipin antibodies . J Rheumatol1995; 22: 2233-2237 .
32.
Cabral AR , Cabiedes J , Alarcon-Segovia D . Antibodies to phospholipid-free β2-glycoprotein-I in patients with primary antiphospholipid syndrome . J Rheumatol1995; 22: 1894-1898 .
33.
Alarcon-Segovia D , Mestanza M , Cabiedes J , Cabral AR . The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to β2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays . J Rheumatol1997; 24: 1545-1551 .
34.
Picillo U , Marcialis MR , Italiano G . Antibodies to β2-glycoprotein I in anticardiolipin negative patients . (Letter.) J Rheumatol1998; 25: 1440-1441 .
Roubey RAS . Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other ‘antiphospho lipid’ autoantibodies . Blood1994; 84: 2854-2867 .
37.
Martinuzzo ME , Forastiero RR , Carreras LO . Anti β2 glycoprotein I antibodies: detection and association with thrombosis . Br J Haematol1995; 89: 397-402 .
38.
Hunt J , Krilis S . The fifth domain of β2-glycoprotein I contains a phospholipid binding site (Cys 281-Cys288) and a region recognized by anticardiolipin antibodies . J Immunol1994; 22: 653-659 .
39.
Petri M . Diagnosis of antiphospholipid antibodies . Rheum Dis Clin N Am1994; 20: 443-469 .
40.
Cucurull E , Espinoza LR , Mendez E et al. Anticardiolipin and anti-β2 glycoprotein-I antibodies in patients with systemic lupus erythematosus: comparison between Colombians and Spaniards . Lupus1999; 8: 134-141 .
41.
Cucurull E , Gharavi A , Diri E , Mendez E , Kapoor D , Espinoza LR . IgA Anticardiolipin and anti-β2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus . Am J Med Sci1999; 318: 55-60 .
42.
Gharavi AE , Harris EN , Asherson RA , Hughes GRV . Anticardiolipin antibodies: isotype distribution and phospholipid specificity . Ann Rheum Dis1987; 46: 1-6 .
43.
Molina JF , Gutierrez-Urena S , Molina J et al. Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus . J Rheumatol1997; 14: 291-296 .
44.
Loizou S , Cofiner C , Weetman AP , Walport MJ . Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders . Clin Exp Immunol1992; 90: 434-439 .
45.
Weidmann CE , Wallace DJ , Peter JB , Knight PJ , Bear MB , Klinenberg JR . Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus . J Rheumatol1988; 15: 74-79 .
46.
Merkel PA , Chang Y , Pierangeli SS et al. The prevalence and clinical associations of Anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases . Am J Med1996; 101: 576-583 .
47.
Lopez LR , Santos ME , Espinoza LR , La Rosa FG . Clinical significance of immunoglobulin A versus immunoglobulins G and M anticardiolipin antibodies in patients with systemic lupus erythematosus . Am J Clin Pathol1992; 98: 449-454 .
48.
Wilson WA , Faghiri Z , Taheri R , Gharavi AE . Significance of IgA antiphospholipid antibodies . Lupus1998; 7: S110-S113 .
49.
Tsutsumi A , Matsuura E , Ichikawa K , Fujisaku A , Mukai M , Koike T . IgA class anti-β2-glycoprotein I in patients with systemic lupus erythematosus . J Rheumatol1998; 25: 74-78 .
50.
Diri E , Cucurull E , Gharavi AE , Kapoor D , Mendez EA , Scopelitis E and Wilson WA . Antiphospholipid (Hughes') syndrome in African American: IgA aCL and aβ2 glycoprotein-I is the most frequent isotype . Lupus1999; 8: 263-268 .
51.
Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for classification of Systemic Lupus Erythematosus . Arthritis Rheum1982; 25: 1271-1277 .
52.
Harris EN , Gharavi AE , Patel SP , Hughes GRV . Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986 . Clin Exp Immunol1987; 68: 215-222 .
53.
Polz E , Wurm H , Kostner GM . Investigations on β2-glycoprotein-I in the rat: isolation from serum and demonstration in lipoprotein density fractions . Int J Biochem1980; 2: 265-270 .
54.
Galen RS , Gambino RS . Beyond Normality. The Predictive Value and Efficiency of Medical Diagnoses. John Wiley: New York , 1993.
55.
Wilson WA , Gharavi AE , Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome . Arthritis Rheum1999; 42: 1309-1311 .
56.
Lockshin MD , Sammaritano LR , Schwartzman S . Validation of the Sapporo criteria for antiphospholipid syndrome . Arthritis Rheum2000; 43: 440-443 .
57.
Wilson WA , Gharavi AE . Genetic risk factors for aPL syndrome . Lupus1996; 5: 398-403 .
58.
Sebastiani GD , Galeazzi M , Morozzi G , Marcolongo R . The immunogenetics of the antiphospholipid syndrome, anticardiolipin anti-bodies and lupus anticoagulant . Semin Arthritis Rheum1996; 25: 414-420 .
59.
Arnett FC , Thiagarajan P , Ahn C , Reveille JD . Associations of anti-β2 glycoprotein I autoantibodies with HLA Class II alleles in three ethnic groups . Arthritis Rheum1999; 42: 268-274 .
60.
Sanghera DK , Kristensen T , Hamman RF , Kamboh MI . Molecular basis of the apolipoprotein H (β2-glycoprotein I) protein polymorphism . Hum Genet1997; 100: 57-62 .
61.
Hirose N , Williams R , Alberts AR et al. A role for the polymorphism at position 247 of the β2-glycoprotein I gene in the generation of antiβ2-glycoprotein I antibodies in the antiphospholipid syndrome . Arthritis Rheum1999; 42: 1655-1661 .
